CD8A and melanoma: We again analyzed the melanoma ICB cohort12 and found that in patients who failed to respond to their therapy, TMED complex expression in CD8 T cells was significantly higher than in those who did respond, irrespective of the time of biopsy and type of ICB (figure 4e and online supplemental figure 5d).